Risk of kidney injury following oral phosphosoda bowel preparations.
Brunelli
Steven M
SM
Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. steven.brunelli@uphs.upenn.edu
Lewis
James D
JD
Gupta
Meera
M
Latif
Sherif M
SM
Weiner
Mark G
MG
Feldman
Harold I
HI
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007422:Intestines / Q000187:drug effects*; D007668:Kidney / Q000187:drug effects* / Q000293:injuries; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000008:administration & dosage* / Q000009:adverse effects*; D012680:Sensitivity and Specificity
D010710:Phosphates; C018279:sodium phosphate